Cargando…
L-DOPA-Induced Motor Impairment and Overexpression of Corticostriatal Synaptic Components Are Improved by the mGluR5 Antagonist MPEP in 6-OHDA-Lesioned Rats
Levodopa (L-DOPA) is still the most effective drug for the treatment of Parkinson’s disease (PD). However, the long-term therapy often triggers L-DOPA-induced dyskinesia (LID). Metabotropic glutamate receptor type 5 (mGluR5) is abundant in the basal ganglia, and its inhibition is thought to modulate...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238196/ https://www.ncbi.nlm.nih.gov/pubmed/30439288 http://dx.doi.org/10.1177/1759091418811021 |
_version_ | 1783371325586276352 |
---|---|
author | Huang, Yixian Shu, Haiyang Li, Li Zhen, Tili Zhao, Junyan Zhou, Xianju Luo, Weifeng |
author_facet | Huang, Yixian Shu, Haiyang Li, Li Zhen, Tili Zhao, Junyan Zhou, Xianju Luo, Weifeng |
author_sort | Huang, Yixian |
collection | PubMed |
description | Levodopa (L-DOPA) is still the most effective drug for the treatment of Parkinson’s disease (PD). However, the long-term therapy often triggers L-DOPA-induced dyskinesia (LID). Metabotropic glutamate receptor type 5 (mGluR5) is abundant in the basal ganglia, and its inhibition is thought to modulate postsynaptic excitatory synaptic transmission and glutamate hyperactivity in PD and LID. In this report, we examined the effects of mGluR5-specific antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) on LID and synaptic components in the PD model rat. We found the selective mGluR5 antagonist MPEP attenuated abnormal involuntary movements, prolonged the duration of rotational response, reversed the decrease of left forepaw adjusting steps, and reduced overexpression of striatal mGluR5 in the LID rats. Moreover, our results showed much thicker postsynaptic densities, narrower synapse cleft, as well as the increased ratio of perforated synapses induced by L-DOPA treatment, while coadministration of L-DOPA and MPEP reversed these postsynaptic effects. Finally, MPEP reduced overexpression of the two postsynaptic proteins (PSD-95 and SAP102) induced by L-DOPA treatment. Hence, these results provide evidence that aberrant neural plasticity at corticostriatal synapses in the striatum is closely correlated with the occurrence of LID, and targeted inhibition of mGluR5 by MPEP alleviates LID in the PD rat model. |
format | Online Article Text |
id | pubmed-6238196 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-62381962018-11-19 L-DOPA-Induced Motor Impairment and Overexpression of Corticostriatal Synaptic Components Are Improved by the mGluR5 Antagonist MPEP in 6-OHDA-Lesioned Rats Huang, Yixian Shu, Haiyang Li, Li Zhen, Tili Zhao, Junyan Zhou, Xianju Luo, Weifeng ASN Neuro Original Paper Levodopa (L-DOPA) is still the most effective drug for the treatment of Parkinson’s disease (PD). However, the long-term therapy often triggers L-DOPA-induced dyskinesia (LID). Metabotropic glutamate receptor type 5 (mGluR5) is abundant in the basal ganglia, and its inhibition is thought to modulate postsynaptic excitatory synaptic transmission and glutamate hyperactivity in PD and LID. In this report, we examined the effects of mGluR5-specific antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) on LID and synaptic components in the PD model rat. We found the selective mGluR5 antagonist MPEP attenuated abnormal involuntary movements, prolonged the duration of rotational response, reversed the decrease of left forepaw adjusting steps, and reduced overexpression of striatal mGluR5 in the LID rats. Moreover, our results showed much thicker postsynaptic densities, narrower synapse cleft, as well as the increased ratio of perforated synapses induced by L-DOPA treatment, while coadministration of L-DOPA and MPEP reversed these postsynaptic effects. Finally, MPEP reduced overexpression of the two postsynaptic proteins (PSD-95 and SAP102) induced by L-DOPA treatment. Hence, these results provide evidence that aberrant neural plasticity at corticostriatal synapses in the striatum is closely correlated with the occurrence of LID, and targeted inhibition of mGluR5 by MPEP alleviates LID in the PD rat model. SAGE Publications 2018-11-15 /pmc/articles/PMC6238196/ /pubmed/30439288 http://dx.doi.org/10.1177/1759091418811021 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Paper Huang, Yixian Shu, Haiyang Li, Li Zhen, Tili Zhao, Junyan Zhou, Xianju Luo, Weifeng L-DOPA-Induced Motor Impairment and Overexpression of Corticostriatal Synaptic Components Are Improved by the mGluR5 Antagonist MPEP in 6-OHDA-Lesioned Rats |
title | L-DOPA-Induced Motor Impairment and Overexpression of Corticostriatal Synaptic Components Are Improved by the mGluR5 Antagonist MPEP in 6-OHDA-Lesioned Rats |
title_full | L-DOPA-Induced Motor Impairment and Overexpression of Corticostriatal Synaptic Components Are Improved by the mGluR5 Antagonist MPEP in 6-OHDA-Lesioned Rats |
title_fullStr | L-DOPA-Induced Motor Impairment and Overexpression of Corticostriatal Synaptic Components Are Improved by the mGluR5 Antagonist MPEP in 6-OHDA-Lesioned Rats |
title_full_unstemmed | L-DOPA-Induced Motor Impairment and Overexpression of Corticostriatal Synaptic Components Are Improved by the mGluR5 Antagonist MPEP in 6-OHDA-Lesioned Rats |
title_short | L-DOPA-Induced Motor Impairment and Overexpression of Corticostriatal Synaptic Components Are Improved by the mGluR5 Antagonist MPEP in 6-OHDA-Lesioned Rats |
title_sort | l-dopa-induced motor impairment and overexpression of corticostriatal synaptic components are improved by the mglur5 antagonist mpep in 6-ohda-lesioned rats |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238196/ https://www.ncbi.nlm.nih.gov/pubmed/30439288 http://dx.doi.org/10.1177/1759091418811021 |
work_keys_str_mv | AT huangyixian ldopainducedmotorimpairmentandoverexpressionofcorticostriatalsynapticcomponentsareimprovedbythemglur5antagonistmpepin6ohdalesionedrats AT shuhaiyang ldopainducedmotorimpairmentandoverexpressionofcorticostriatalsynapticcomponentsareimprovedbythemglur5antagonistmpepin6ohdalesionedrats AT lili ldopainducedmotorimpairmentandoverexpressionofcorticostriatalsynapticcomponentsareimprovedbythemglur5antagonistmpepin6ohdalesionedrats AT zhentili ldopainducedmotorimpairmentandoverexpressionofcorticostriatalsynapticcomponentsareimprovedbythemglur5antagonistmpepin6ohdalesionedrats AT zhaojunyan ldopainducedmotorimpairmentandoverexpressionofcorticostriatalsynapticcomponentsareimprovedbythemglur5antagonistmpepin6ohdalesionedrats AT zhouxianju ldopainducedmotorimpairmentandoverexpressionofcorticostriatalsynapticcomponentsareimprovedbythemglur5antagonistmpepin6ohdalesionedrats AT luoweifeng ldopainducedmotorimpairmentandoverexpressionofcorticostriatalsynapticcomponentsareimprovedbythemglur5antagonistmpepin6ohdalesionedrats |